EMA Authorised: Menveo (meningococcal group A, C, W-135 and Y conjugate vaccine) — GSK Vaccines S.r.l.

View source ↗

Summary

The European Medicines Agency has authorised Menveo, a meningococcal group A, C, W-135 and Y conjugate vaccine by GSK Vaccines S.r.l., for immunization against …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis
• Meningococcal Disease

Drugs mentioned

• Menveo (meningococcal group A, C, W-135 and Y conjugate vaccine)

Snippet

Status: Authorised. Therapeutic area: Immunization;Meningitis, Meningococcal. MAH: GSK Vaccines S.r.l.. Decision date: 25/06/2026